Streptokinase
Streptokinase.JPG

CLINICAL USE

Fibrinolytic:Thrombolysis in DVT, PE, acute arterial thromboembolism, acute MI, thrombosed A-V shunts

DOSE IN NORMAL RENAL FUNCTION

Loading dose: 250 000 IU followed by 100 000 IU/hour for 12–72 hours (refer to SPC)Myocardial Infarction: 1.5 MIU followed by aspirinThrombosed
  • HD                     : shunts: 10–25 000 IU sealed in shunt and repeated after 30–45 minutes

    PHARMACOKINETICS

  • Molecular weight                           :47 408
  • %Protein binding                           :No data
  • %Excreted unchanged in urine     : 0
  • Volume of distribution (L/kg)       :0.02–0.08
  • half-life – normal/ESRD (hrs)      :18 minutes/–

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Not dialysed. Dose as in normal renal function
  • HD                     :Not dialysed. Dose as in normal renal function
  • HDF/high flux   :Unlikely to be dialysed. Dose as in normal renal function
  • CAV/VVHD      :Not dialysed. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugsAnticoagulants should not be given with streptokinaseHeparin infusions should be stopped 4 hours before streptokinase infusion. If this is not possible, protamine sulphate should be used to neutralise the heparin; heparin infusions can be restarted 4 hours post streptokinase infusion followed by oral anticoagulants

    ADMINISTRATION

    Reconstition

    See manufacturer’s literature

    Route

    IV

    Rate of Administration

    Give loading dose of 250 000 IU in 100 mL fluid over 30 minutes, followed by an appropriate volume for the maintenance doseGive 1.5 MIU for acute MI in 50–200 mL fluid over 1 hour

    Comments

    For occluded
  • HD                     : shunts, add 100 000 IU to 100 mL sodium chloride 0.9% and put 10–25 mL into the clotted portion of the shunt

    OTHER INFORMATION

    There are no significant changes in pharmacokinetics in patients with renal insufficiency. Dosage reduction is therefore not necessary.



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs